Lexington Clinic Grand Rounds 2025

Lexington Clinic Grand Rounds

Course Description:
This regularly scheduled series will provide new clinical information on topics relevant to best practices of physicians administering clinical care in a wide range of specialties across Kentucky.

Statement of Need:
Physicians need to obtain new information related to clinical treatment and new/changes to clinical guidelines.

Objectives, Topics and Disclosure Information:
Physicians attending this conference regularly will be apprised of recent advances in medicine that will lead to improved patient care.

Session specific topic objectives are listed below and will be updated as content is developed.

These courses expire December 31, 2025.

Month

Presenter

Date of
Presentation

Links to Educational Activities
and Evaluations

Objectives

Disclosure*

February

Karabeth Moore, M.D., FACS

2/19/2025 

Click here for video
Note: .5 AMA PRA Category credit.™

Click here for survey 

Considerations of Breast Surgery 

 

  • Define breast conservation
  • Discuss literature that justifies breast conservation versus mastectomy
  • Indications and contraindications for breast conservation
  • Define margin and current consensus regarding margins
  • Define Oncoplastics
  • Describe differences in surgical techniques

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

March

Ryan G. Fischer, M.D., FAAD

3/19/25

Click here for video

Click here for survey 

 

New Medications in Dermatology:  Disease Indications, Mechanisms of Action and Adverse Effects

 

  • Review the new medications being used in dermatology
  • Describe the mechanism of action of these medications
  • Outline the indications for these new medications
  • Examine common adverse effects of these medications and how to address them

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

April

Walaa Ayoub, M.D., PhD

4/16/25

Click here for video

Click here for survey

Trabecular Bone Score [TBS] – A Journey Through Osteoporosis From A Disease of Too Little Bone To Our Current Understanding

 

  • Describe how to assess bone quality using Trabecular Bone Score (TBS)
  • Describe diagnosis and treatment ofosteoporosis
  • Be able to apply TBS score andimplement treatment.

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

May

Sara Min, M.D.

5/21/25 

 

Crystalline Arthritis 

 

  • Describe mechanisms to evaluate for gout and pseudogout
  • Discuss risk factors and pathogenesis of crystalline arthritis
  • Be able to determine treatment options for patients.

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

June

Mark Sloan, M.D., FACEP

6/18/25 

 

Emergency Medicine

  • Identify core endocrine crisis quickly and initiate appropriate evidence based medical treatment to stabilize. 

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

July

Maria Belcastro, M.D.

7/16/25 

 

Evidence-Based Review for Primary Care on the Management of Outpatient Alcohol Dependence

  • Describe and outline approaches for effective communication with patients regarding alcohol use.
  • Describe treatment options including counseling and medication for alcohol abuse.
  • Describe tools to support outpatient management of alcohol detox.

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

August

Cody Stover, M.D.

8/20/25 

 

Kinematic Alignment of Total Knee Arthroplasty

  • Describe differences between mechanical and kinematic alignment.
  • Describe surgical methods to obtain a kinematic alignment.
  • Describe recovery considerations for patients.

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

September

Benjamin McKenzie, M.D.

9/17/25

Immunizations

  • Describe impact of vaccines on patient outcomes
  • Discuss special patient population considerations related to vaccine priority
  • Describe approaches to effective counseling with patients to address vaccine hesitancy
  • Describe emerging vaccines/changes to vaccines

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

October

Katrina Hood, M.D.

10/15/25

Childhood Vaccines

  • Review the latest recommendations for childhood immunizations: Update healthcare professionals on any changes to the recommended vaccine schedule
  • Improve vaccine communication skills: Provide strategies for effectively addressing parental concerns and hesitancy about vaccines.
  • Review new vaccines over the last twenty years

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients 

 

November

Elaine Alexander, M.D.

11/19/25 

 

Rheumatology Perspectives in Interstitial Lung Disease

  • Identify rheumatologic conditions that are commonly associated with development of interstitial lung disease
  • Improve familiarity with screening processes
  • Describe stepwise approach to investigating and managing progressive interstitial lung disease in different rheumatologic conditions
  • Summarize treatment options and risk vs. benefits of each

The speaker and planners disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients 

 

December NO SESSION

*All planners discloses that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Commercial Support: There is no commercial support associated with this activity.

Accreditation and Designation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a Joint Providership of the Kentucky Medical Association and the Lexington Clinic. The Kentucky Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Kentucky Medical Association designates this enduring material activity for 1.oo AMA PRA Category 1 credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Estimated Time to Complete: This module will take approximately 1 hour to complete

Method of Participation Used: Participants will view and listen to a recorded lecture while simultaneously viewing slides.

Hardware/Software Requirements: High speed internet connection

Meeting Planner: Miranda Mosley, Rachel Crouch

Provider Contact Information: Miranda Mosley, Kentucky Medical Association

Copyright: There is no copyright associated with this activity

Release Date: January 2025

Termination Date: December 2025